Source: ERS course 2015
Disease area: Airway diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
W. Windisch (Cologne, Germany), P.J. Wijkstra (Groningen, Netherlands). Long term application of NIV in COPD - PRO & CON. ERS course 2015

Member's Comments

No comment yet.

Related content which might interest you: NIV and pneumonia - PRO & CON Source: ERS course 2015 Year: 2015 Long term NIV Source: ERS course 2015 Year: 2015 Indacaterol/glycopyrronium (IND/GLY) reduces days with COPD exacerbation vs salmeterol/fluticasone (SFC) independent of PRO tool: results of the FLAME study Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Evolving use of long-term NIV in COPD: Are we getting it right Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013 Long term effects of non-invasive ventilation (NIV) in hypercapnic COPD – preliminary results of a randomized controlled pilot study Source: Annual Congress 2009 - New trends in noninvasive ventilation for chronic respiratory failure Year: 2009 Long term non-invasive ventilation following acute respiratory failure in COPD: results at one year Source: Annual Congress 2007 - Long-term home mechanical ventilation with noninvasive ventilation Year: 2007 NIV to facilitate weaning: not only COPD Source: International Congress 2015 – Weaning from mechanical ventilation: new insights Year: 2015 PRO - NIV in acute hypoxemic failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Efficiency, acceptance and tolerance of long term non invasive ventilation (NIV) in chronic respiratory failure (CRF) Source: Virtual Congress 2020 – Home non-invasive ventilation: (long-term) effects and prognosis Year: 2020 The TORCH (TOwards a Revolution in COPD Health) study: salmeterol/fluticasone propionate (SFC) improves survival in COPD over three years Source: Eur Respir J 2006; 28: Suppl. 50, 34s Year: 2006 Validation of the COPD control concept: A UK pilot Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Efficacy of indacaterol/glycopyrronium (IND/GLY) versus salmeterol/fluticasone (SFC) on exacerbations and health status in GOLD Group D COPD patients: The FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Does exercising COPD patients on non invasive ventilation (NIV) enable them to walk further? A randomised controlled trial Source: International Congress 2014 – Key factors that ensure noninvasive ventilation success Year: 2014 Update on long term NIV Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Improving standards of NIV - Simulation training Source: International Congress 2015 – New developments in medical education, web and internet Year: 2015 Onbrace: A real-life evaluation of indacaterol maintenance treatment for COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 PRO - Steroids in ARDS Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020